Mirus Bio

Mirus Bio is a leading provider of transfection products for the biopharmaceutical and research industries, offering best-in-class reagents for gene therapy, recombinant protein, and stem cell applications. A pioneer in nucleic acid delivery, the company has been enabling scientific research and innovation for more than two decades. In 2021, Mirus introduced VirusGEN® GMP Transfection Reagent and Enhancers addressing the commercial biopharmaceutical and cell and gene therapy markets to support virus manufacturing, gene editing, and biotherapeutic protein production.